- Home
- NYXH vs BCV Comparison
NYXH vs BCV Comparison
Compare NYXH & BCV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NYXH | BCV |
|---|---|---|
| Founded | 2009 | 1971 |
| Country | Belgium | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 152.8M | 128.4M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | NYXH | BCV |
|---|---|---|
| Price | $3.31 | $21.80 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $11.25 | N/A |
| AVG Volume (30 Days) | ★ 55.8K | 14.4K |
| Earning Date | 05-13-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 8.13% |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $214.32 | N/A |
| Revenue Next Year | $124.13 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.76 | $15.63 |
| 52 Week High | $8.64 | $24.55 |
Technical Indicators
Market Signals| Indicator | NYXH | BCV |
|---|---|---|
| Relative Strength Index (RSI) | 45.83 | 43.29 |
| Support Level | $2.76 | $21.25 |
| Resistance Level | $3.32 | $22.69 |
| Average True Range (ATR) | 0.18 | 0.50 |
| MACD | 0.09 | 0.01 |
| Stochastic Oscillator | 59.66 | 32.87 |
Price Performance
Historical ComparisonAbout NYXH Nyxoah SA
Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The company's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.
About BCV Bancroft Fund Ltd.
Bancroft Fund Ltd is a diversified closed-end management company. It operates as a closed-ended equity mutual fund. The funds' main objective is to provide income and potential for capital appreciation. With the intent to achieve its objective, the company invests in convertible and equity securities. It invests across different industries such as Computer Software and Services, Energy and Utilities, Health Care among others.